{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:05:34Z","timestamp":1769159134592,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"44","license":[{"start":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T00:00:00Z","timestamp":1425254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/onc.2015.19","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T11:00:08Z","timestamp":1425294008000},"page":"5593-5598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases"],"prefix":"10.1038","volume":"34","author":[{"given":"C","family":"Leroy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Strande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M E","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Lezan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bentires-Alj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Voshol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Bonenfant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Alex Gaither","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,2]]},"reference":[{"key":"BFonc201519_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1349-7006.2008.01066.x","volume":"100","author":"J Ikeda","year":"2009","unstructured":"Ikeda J, Oda T, Inoue M, Uekita T, Sakai R, Okumura M et al. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci 2009; 100: 429\u2013433.","journal-title":"Cancer Sci"},{"key":"BFonc201519_CR2","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1158\/1078-0432.CCR-08-2533","volume":"15","author":"CH Wong","year":"2009","unstructured":"Wong CH, Baehner FL, Spassov DS, Ahuja D, Wang D, Hann B et al. Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers. Clin Cancer Res 2009; 15: 2311\u20132322.","journal-title":"Clin Cancer Res"},{"key":"BFonc201519_CR3","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1073\/pnas.1011777108","volume":"108","author":"OV Razorenova","year":"2011","unstructured":"Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK et al. VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration. Proc Natl Acad Sci USA 2011; 108: 1931\u20131936.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201519_CR4","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1158\/0008-5472.CAN-07-1657","volume":"68","author":"AC Siva","year":"2008","unstructured":"Siva AC, Wild MA, Kirkland RE, Nolan MJ, Lin B, Maruyama T et al. Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model. Cancer Res 2008; 68: 3759\u20133766.","journal-title":"Cancer Res"},{"key":"BFonc201519_CR5","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1158\/0008-5472.CAN-10-0220","volume":"70","author":"Y Miyazawa","year":"2010","unstructured":"Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y et al. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res 2010; 70: 5136\u20135146.","journal-title":"Cancer Res"},{"key":"BFonc201519_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/path.2026","volume":"210","author":"JI Ikeda","year":"2006","unstructured":"Ikeda JI, Morii E, Kimura H, Tomita Y, Takakuwa T, Hasegawa JI et al. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells. J Pathol 2006; 210: 75\u201384.","journal-title":"J Pathol"},{"key":"BFonc201519_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2005.02.019","volume":"121","author":"CH Benes","year":"2005","unstructured":"Benes CH, Wu N, Elia AE, Dharia T, Cantley LC, Soltoff SP . The C2 domain of PKCdelta is a phosphotyrosine binding domain. Cell 2005; 121: 271\u2013280.","journal-title":"Cell"},{"key":"BFonc201519_CR8","doi-asserted-by":"publisher","first-page":"14772","DOI":"10.1074\/jbc.M309678200","volume":"279","author":"TA Brown","year":"2004","unstructured":"Brown TA, Yang TM, Zaitsevskaia T, Xia Y, Dunn CA, Sigle RO et al. Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80\/gp140\/CUB domain-containing protein 1 in epithelia. J Biol Chem 2004; 279: 14772\u201314783.","journal-title":"J Biol Chem"},{"key":"BFonc201519_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrclinonc.2009.129","volume":"6","author":"LC Kim","year":"2009","unstructured":"Kim LC, Song L, Haura EB . Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 2009; 6: 587\u2013595.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFonc201519_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1600-065X.2008.00745.x","volume":"228","author":"RJ Salmond","year":"2009","unstructured":"Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R . T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 2009; 228: 9\u201322.","journal-title":"Immunol Rev"},{"key":"BFonc201519_CR11","doi-asserted-by":"publisher","first-page":"20716","DOI":"10.1074\/jbc.M301689200","volume":"278","author":"R Verma","year":"2003","unstructured":"Verma R, Wharram B, Kovari I, Kunkel R, Nihalani D, Wary KK et al. Fyn binds to and phosphorylates the kidney slit diaphragm component Nephrin. J Biol Chem 2003; 278: 20716\u201320723.","journal-title":"J Biol Chem"},{"key":"BFonc201519_CR12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1073\/pnas.1017228108","volume":"108","author":"H Liu","year":"2011","unstructured":"Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM, Hynes RO . CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci USA 2011; 108: 1379\u20131384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201519_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.molcel.2008.03.026","volume":"30","author":"C Oneyama","year":"2008","unstructured":"Oneyama C, Hikita T, Enya K, Dobenecker MW, Saito K, Nada S et al. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src. Mol Cell 2008; 30: 426\u2013436.","journal-title":"Mol Cell"},{"key":"BFonc201519_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/onc.2009.450","volume":"29","author":"A Sirvent","year":"2010","unstructured":"Sirvent A, Benistant C, Pannequin J, Veracini L, Simon V, Bourgaux JF et al. Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization. Oncogene 2010; 29: 1303\u20131315.","journal-title":"Oncogene"},{"key":"BFonc201519_CR15","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1128\/MCB.20.10.3396-3406.2000","volume":"20","author":"G Manes","year":"2000","unstructured":"Manes G, Bello P, Roche S . Slap negatively regulates Src mitogenic function but does not revert Src-induced cell morphology changes. Mol Cell Biol 2000; 20: 3396\u20133406.","journal-title":"Mol Cell Biol"},{"key":"BFonc201519_CR16","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/ncomms4159","volume":"5","author":"C Naudin","year":"2014","unstructured":"Naudin C, Sirvent A, Leroy C, Larive R, Simon V, Pannequin J et al. SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2. Nat Commun 2014; 5: 3159.","journal-title":"Nat Commun"},{"key":"BFonc201519_CR17","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1158\/0008-5472.CAN-12-3186","volume":"73","author":"A Alajati","year":"2013","unstructured":"Alajati A, Sausgruber N, Aceto N, Duss S, Sarret S, Voshol H et al. Mammary tumor formation and metastasis evoked by a HER2 splice variant. Cancer Res 2013; 73: 5320\u20135327.","journal-title":"Cancer Res"},{"key":"BFonc201519_CR18","doi-asserted-by":"publisher","first-page":"9391","DOI":"10.1158\/0008-5472.CAN-10-0911","volume":"70","author":"F Hochgrafe","year":"2010","unstructured":"Hochgrafe F, Zhang L, O'Toole SA, Browne BC, Pinese M, Porta Cubas A et al. Tyrosine phosphorylation profiling reveals the signaling network characteristics of basal breast cancer cells. Cancer Res 2010; 70: 9391\u20139401.","journal-title":"Cancer Res"},{"key":"BFonc201519_CR19","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/j.1349-7006.2011.02052.x","volume":"102","author":"T Uekita","year":"2011","unstructured":"Uekita T, Sakai R . Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis. Cancer Sci 2011; 102: 1943\u20131948.","journal-title":"Cancer Sci"},{"key":"BFonc201519_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/iub.198","volume":"61","author":"A Wortmann","year":"2009","unstructured":"Wortmann A, He Y, Deryugina EI, Quigley JP, Hooper JD . The cell surface glycoprotein CDCP1 in cancer\u2014insights, opportunities, and challenges. IUBMB Life 2009; 61: 723\u2013730.","journal-title":"IUBMB Life"},{"key":"BFonc201519_CR21","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1158\/0008-5472.CAN-08-2354","volume":"69","author":"C Leroy","year":"2009","unstructured":"Leroy C, Fialin C, Sirvent A, Simon V, Urbach S, Poncet J et al. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. Cancer Res 2009; 69: 2279\u20132286.","journal-title":"Cancer Res"},{"key":"BFonc201519_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/onc.2012.547","volume":"33","author":"B Casar","year":"2014","unstructured":"Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI . In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated beta1 integrin and induction of FAK\/PI3K\/Akt motility signaling. Oncogene 2014; 33: 255\u2013268.","journal-title":"Oncogene"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc201519.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc201519","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc201519.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:58:19Z","timestamp":1684472299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,2]]},"references-count":22,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFonc201519"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.19","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,2]]},"assertion":[{"value":"3 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are employees of Novartis. CL is a presidential postdoctoral fellow at the Novartis Institutes for Biomedical Research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}